This month, the FDA released new guidance on “Conduct of Clinical Trials of Medical Products during the COVID- 19 Pandemic“. Here, the FDA recognizes the potential for unavoidable protocol deviations to ensure the safety of trial participants and maintain data integrity during this unprecedented time.

With COVID-19 having a profound impact on today’s clinical trial conduct, the industry must look to the virtualization of clinical trials to stay ahead of the curve. Learn more by attending ExL Events’ Virtual Clinical Trial Online Conference this April 22 – April 23.